Whereas similar anti-tumor effects of NF-κB have been observed in a breast cancer metastasis model (96), myeloid IKK2 deletion demonstrated beneficial effects in colitis-induced cancer (97) and hepatocellular carcinoma (98, 99). Here, NFKB1 is linked to neoplasm.